dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 37 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: P01 GM081619
NIGMS NIH HHS
Grant: R01 GM083867
NCI NIH HHS
Grant: U01 CA246503
National Institutes of Health
Grant: R01GM97372-03S1
American Heart Association
Grant: 19IPLOI34760143
NHGRI NIH HHS
Grant: R42 HG010855
National Institutes of Health
Grant: 1P01GM081619
NIGMS NIH HHS
Grant: R01 GM097372
American Heart Association
Grant: 17/434,832
National Institutes of Health
Grant: DOD PR203328 W81XWH-21-1-0006
National Institutes of Health
Grant: 3R01GM083867-02S2
MicroRNA Function in Human Embryonic Stem Cells
National Institutes of Health
Grant: 1R01GM097372-01
Acquisition of Embryonic Stem Cell Metabolic Signature
National Institutes of Health
Grant: 5U01CA246503-04
Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker Assay
National Institutes of Health
Grant: 5P01GM081619-02
Cardiac Differentiation from Human Embryonic Stem Cells
National Institutes of Health
Grant: 1R42HG010855-01A1
PIXUL-FFPE: High throughput platform for chromatin and DNA sample preparation from formalin fixed paraffin embedded (FFPE) tissue samples.
Stanford University
US Department of Defense
Fields of Study
MeSH Terms
Keywords
Additional file 1 of CryoGrid-PIXUL-RNA: high throughput RNA isolation platform for tissue transcript analysis
Additional file 1 of CryoGrid-PIXUL-RNA: high throughput RNA isolation platform for tissue transcript analysis
Additional file 1 of Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer
Additional file 1 of Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer
Additional file 4 of Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer
Additional file 5 of Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer
Additional file 5 of Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer
Additional file 4 of Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer
Additional file 2 of Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer
Additional file 3 of Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer
Additional file 2 of Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer
Additional file 3 of Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer